Summary & Overview
HCPCS C1833: Implantable Cardiac Monitor with Intracardiac Lead
HCPCS Level II code C1833 designates an implantable cardiac monitor that includes an intracardiac lead and all necessary system components. This device-level code matters nationally because implantable cardiac monitors are critical for long-term cardiac rhythm surveillance, management of arrhythmias, and guiding downstream clinical and procedural decisions. Accurate coding affects device tracking, hospital reimbursement for implantable device supplies, and payer adjudication.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for device use, typical sites of service where implantation occurs, and the payer landscape addressed. The publication provides benchmarks for coverage and reimbursement where available, common billing considerations tied to device implantation and supply coding, and a summary of policy or coding updates impacting claims for implantable cardiac monitoring systems. Where input data is missing, the document notes that specific items are not available in the input.
Billing Code Overview
HCPCS Level II code C1833 describes an implantable cardiac monitor system, specifically a monitor that includes an intracardiac lead and all system components. The service type derived from this description is implantable cardiac monitoring device placement and management. The typical site of service for procedures and claims using this code is an inpatient or outpatient surgical setting or an ambulatory surgical center, where device implantation and related device services are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old man with ischemic cardiomyopathy and symptomatic episodes of syncope is evaluated for an implantable cardiac monitor with intracardiac lead placement. He has recurrent unexplained palpitations and near-syncope despite ambulatory external monitoring. After cardiology consultation and preoperative evaluation including informed consent, anticoagulation management, and device selection, the patient is taken to an electrophysiology lab or cardiac catheterization suite. Under sterile technique and conscious sedation or monitored anesthesia care, an implantable cardiac monitor system with intracardiac lead and all system components is implanted via a transvenous approach. Post-implant device testing confirms lead integrity, sensing thresholds, and appropriate telemetry. The patient receives post-procedure recovery monitoring, device programming and education on wound care and remote monitoring enrollment, and is discharged with follow-up arranged in the device clinic for interrogation and possible programming adjustments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the implant procedure requires substantially greater work or complexity than typical, documented in the operative report. |
51 |